DR. HARRY D. BEAR, M.D.
Radiology at Marshall St, Richmond, VA
License number
Virginia 0101027958
Category
Radiology
Type
Surgery
Address
Address
1250 E Marshall St, Richmond, VA 23298
Phone
(804) 828-9325
(804) 828-4808 (Fax)
(804) 358-6100
(804) 342-7619 (Fax)
(804) 828-4808 (Fax)
(804) 358-6100
(804) 342-7619 (Fax)
Personal information
See more information about HARRY D. BEAR at radaris.comName
Address
Phone
10811 Weather Vane Rd, Richmond, VA 23238
3713 Nottaway St, Norfolk, VA 23513
10811 Weather Vane Rd, Richmond, VA 23233
3713 Nottaway St, Norfolk, VA 23513
10811 Weather Vane, Henrico, VA 23238
Organization information
See more information about HARRY D. BEAR at bizstanding.comHarry D Bear MD
Stony Pt, Richmond, VA 23235
Categories:
General Surgeons, Oncology Physicians & Surgeons, Physicians & Surgeons
Phone:
(804) 560-8950 (Phone)
Harry D Bear MD
PO Box 980011, Richmond, VA 23298
Categories:
Oncology Physicians & Surgeons
Phone:
(804) 828-9324 (Phone)
Professional information
Harry D Bear, Richmond VA
Specialties:
Surgery, Surgical Oncology, Vascular Surgery, Medical Oncology
Work:
VCU Health System
9000 Stony Point Pkwy, Richmond, VA 23235 VCU Health System
401 College St, Richmond, VA 23298 Vcuhs
1200 E Broad St, Richmond, VA 23298 VCU Health System
1250 E Marshall St, Richmond, VA 23298 TRI Cities Outpatient Rehabilitation
411 W Randolph Rd, Hopewell, VA 23860
9000 Stony Point Pkwy, Richmond, VA 23235 VCU Health System
401 College St, Richmond, VA 23298 Vcuhs
1200 E Broad St, Richmond, VA 23298 VCU Health System
1250 E Marshall St, Richmond, VA 23298 TRI Cities Outpatient Rehabilitation
411 W Randolph Rd, Hopewell, VA 23860
Education:
Virginia Commonwealth University (1975)
Harry D Bear, Richmond VA
Specialties:
Surgeon
Address:
1250 E Marshall St, Richmond, VA 23298
Education:
Virginia Commonwealth University - Doctor of Philosophy
Virginia Commonwealth University, School of Medicine - Doctor of Medicine
Brigham & Women's Hospital - Residency - Surgery
Virginia Commonwealth University, School of Medicine - Doctor of Medicine
Brigham & Women's Hospital - Residency - Surgery
Board certifications:
American Board of Surgery Certification in Surgery
Composition And Method For Immunological Treatment Of Cancer, Prevention Of Cancer Recurrence And Metastasis, And Overcoming Immune Suppresor Cells
US Patent:
2013030, Nov 21, 2013
Filed:
May 5, 2011
Appl. No.:
13/877536
Inventors:
Masoud H. Manjili - Richmond VA, US
Harry D. Bear - Richmond VA, US
Maciej Kmieciak - Richmond VA, US
Harry D. Bear - Richmond VA, US
Maciej Kmieciak - Richmond VA, US
Assignee:
VIRGINIA COMMONWEALTH UNIVERSITY - Richmond VA
International Classification:
C12N 5/0783, C12N 5/0784
US Classification:
424 9371, 435375, 435377
Abstract:
Methods for the ex vivo generation of cells of the innate (NKT cells and NK cells) and adaptive (T cells) immune systems for use in adoptive cell transfer (ACT) are provided. The NKT cells render T cells resistant to immune suppression (e.g. they are resistant to the effects of myeloid-derived suppressor cells (MDSCs)). The method involves culturing disease-primed immune cells (obtained from a cancer patient or from a patient with an infectious disease) with i) byrostatin and ionomycin (B/I) to activate and differentiate the cells; followed by sequentially culturing the cells with a) a combination of IL-7 and IL-15 and then b) IL-2, to further differentiate the cells and to render them immune resistant. The resistant immune cells are used to treat and prevent cancer and infectious diseases.
Signatures Associated With Rejection Or Recurrence Of Cancer
US Patent:
2011003, Feb 10, 2011
Filed:
Aug 20, 2010
Appl. No.:
12/859933
Inventors:
Masoud Manjili - Richmond VA, US
Maciej Kmieciak - Richmond VA, US
Harry D. Bear - Richmond VA, US
Catherine I. Dumur - Richmond VA, US
Michael O. Idowu - Richmond VA, US
Maciej Kmieciak - Richmond VA, US
Harry D. Bear - Richmond VA, US
Catherine I. Dumur - Richmond VA, US
Michael O. Idowu - Richmond VA, US
International Classification:
C40B 30/04, C12Q 1/68, C12M 1/34, C40B 40/06, C40B 60/12
US Classification:
506 9, 435 6, 4352872, 506 16, 506 39
Abstract:
Methods and tools for assessing the prognosis for patients following treatment of primary tumors are provided. The methods involve identifying immune-related genetic markers whose differential expression patterns at tumor lesions are indicative of either tumor recurrence or recurrence-free survival. The methods and tools of the invention assist physicians by providing objective decision-making tools for planning patient treatment protocols.